Furthermore, tumor cells could disrupt methionine metabolism in CD8+ T cells, leading to lower intracellular levels of methionine and the methyl donor S-adenosylmethionine (SAM), as well as the loss of H3K79me2, resulting in the low expression of STAT5 and impaired T cell immunity [101]. The gene discussed is CD8A; the disease is neoplasm.